Biotechnology Company Announces Major Agreement For Worldwide Exclusive Rights
Kineta Announces Exclusivity and Right of First Offer Agreement for VISTA Blocking Antibody with TuHURA Biosciences.
Disclaimer: The information provided in this article is based on the announcement made by Kineta, Inc. and is intended solely for informational purposes. It should not be construed as investment advice or an endorsement of any company or product.
Real-time information is available daily at https://stockregion.net